Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, May 31, 2016

FDA warns against fake Hepatitis C medicines

FDA warns against fake Hepatitis C medicines

The Philippines' Food and Drug Administration (FDA) has warned against a fake Hepatitis C medicines circulating in Southeast Asia.

The FDA said the fake medicine brands include: Sofosbuvir + Ledipasvir (Ledso) 400 mg/ 90 mg capsule Daclatasvir (Dakavir) 60 mg capsule It said that based on an advisory from the World Health Organization (WHO) the fake medicines have been circulating around South Est Asia and "may reach the Philippine market."

Continue reading....


No comments:

Post a Comment